Universität zu Köln

Journal Article

Denkert, Carsten, Seither, Fenja, Schneeweiss, Andreas, Link, Theresa, Blohmer, Jens-Uwe, Just, Marianne, Wimberger, Pauline, Forberger, Almuth, Tesch, Hans, Jackisch, Christian, Schmatloch, Sabine, Reinisch, Mattea, Solomayer, Erich F., Schmitt, Wolfgang D., Hanusch, Claus, Fasching, Peter A., Luebbe, Kristina, Solbach, Christine, Huober, Jens, Rhiem, Kerstin, Marme, Frederik, Reimer, Toralf, Schmidt, Marcus ORCID: 0000-0003-1365-2414, Sinn, Bruno, V, Janni, Wolfgang, Stickeler, Elmar, Michel, Laura, Stoetzer, Oliver, Hahnen, Eric, Furlanetto, Jenny, Seiler, Sabine, Nekljudova, Valentina, Untch, Michael and Loibl, Sibylle (2021). Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Lancet Oncol., 22 (8). S. 1151 - 1162. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Furlanetto, Jenny, Moebus, Volker, Schneeweiss, Andreas, Rhiem, Kerstin, Tesch, Hans, Blohmer, Jens-Uwe, Luebbe, Kristina, Untch, Michael, Salat, Christoph, Huober, Jens, Klare, Peter, Schmutzler, Rita, Couch, Fergus J., Lederer, Bianca, Gerber, Bernd, Zahm, Dirk-Michael, Bauerfeind, Ingo, Nekljudova, Valentina, Hanusch, Claus, Jackisch, Christian, Link, Theresa, Loibl, Sibylle and Fasching, Peter A. (2020). Germline (G)BRCA1/2 Mutations (M) and Hematological Toxicities in Patients (PTS) with Triple Negative Breast Cancer (TNBC) Treated with Neoadjuvant Chemotherapy (NACT). Oncol. Res. Treat., 43. S. 22 - 23. BASEL: KARGER. ISSN 2296-5262

Furlanetto, Jenny, Moebus, Volker, Schneeweiss, Andreas, Rhiem, Kerstin, Tesch, Hans, Blohmer, Jens-Uwe ORCID: 0000-0002-7969-250X, Luebbe, Kristina, Untch, Michael, Salat, Christoph, Huober, Jens, Klare, Peter, Schmutzler, Rita, Couch, Fergus J., Lederer, Bianca, Gerber, Bernd, Zahm, Dirk-Michael, Bauerfeind, Ingo, Nekljudova, Valentina, Hanusch, Claus, Jackisch, Christian, Link, Theresa, Hahnen, Eric, Loibl, Sibylle and Fasching, Peter A. (2021). Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy. Eur. J. Cancer, 145. S. 44 - 53. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Loibl, Sibylle, Untch, Michael, Burchardi, Nicole, Huober, Jens Bodo, Blohmer, Jens U., Grischke, Eva-Maria, Furlanetto, Jenny, Tesch, Hans, Hanusch, Claus, Rezai, Mahdi, Jackisch, Christian, Schmitt, Wolfgang D., Von Minckwitz, Gunter, Thomalla, Jorg, Kummel, Sherko, Rautenberg, Beate, Fasching, Peter A., Rhiem, Kerstin, Denkert, Carsten and Schneeweiss, Andreas (2018). Randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC). J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Pohl-Rescigno, Esther, Hauke, Jan, Loibl, Sibylle, Moebus, Volker, Denkert, Carsten, Fasching, Peter A., Kayali, Mohamad, Ernst, Corinna ORCID: 0000-0001-7756-8815, Weber-Lassalle, Nana, Hanusch, Claus, Tesch, Hans, Mueller, Volkmar, Altmueller, Janine, Thiele, Holger ORCID: 0000-0002-0169-998X, Untch, Michael, Luebbe, Kristina, Nuernberg, Peter, Rhiem, Kerstin, Furlanetto, Jenny, Lederer, Bianca, Jackisch, Christian, Nekljudova, Valentina, Schmutzler, Rita K., Schneeweiss, Andreas and Hahnen, Eric (2020). Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer A Secondary Analysis of the GeparOcto Randomized Clinical Trial. JAMA Oncol., 6 (5). S. 744 - 749. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

Pohl-Rescigno, Esther, Hauke, Jan, Rhiem, Kerstin, Moebus, Volker, Furlanetto, Jenny, Denkert, Carsten, Fasching, Peter A., Hanusch, Claus, Tesch, Hans, Weber-Lassalle, Nana, Mueller, Volkmar, Untch, Michael, Luebbe, Kristina, Lederer, Bianca, Jackisch, Christian, Nekljudova, Valentina, Schmutzler, Rita K., Loibl, Sibylle, Schneeweiss, Andreas and Hahnen, Eric (2020). Germline Mutation Status and Therapy Response in High-Risk Early-Stage Breast Cancer: a Secondary Analysis of the Geparocto Randomized Clinical Trial (NCT02125344). Oncol. Res. Treat., 43. S. 7 - 9. BASEL: KARGER. ISSN 2296-5262

Schneeweiss, Andreas, Jackisch, Christian, Schmatloch, Sabine, Aktas, Bahriye, Denkert, Carsten, Schem, Christian, Wiebringhaus, Hermann, Kummel, Sherko, Rhiem, Kerstin, Warm, Mathias, Fasching, Peter A., Just, Marianne, Hanusch, Claus, Hackmann, John, Blohmer, Jens Uwe, Gerber, Bernd, Furlanetto, Jenny, von Minckwitz, Gunter, Nekljudova, Valentina, Loibl, Sibylle and Untch, Michael (2018). Survival analysis of the prospectively randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy with weekly nab-paclitaxel with solvent-based paclitaxel followed by anthracycline/cyclophosphamide for patients with early breast cancer-GBG69. Cancer Res., 78 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Untch, Michael, Jackisch, Christian, Schneeweiss, Andreas, Schmatloch, Sabine, Aktas, Bahriye, Denkert, Carsten, Schem, Christian, Wiebringhaus, Hermann, Kuemmel, Sherko, Warm, Mathias, Fasching, Peter A., Just, Marianne, Hanusch, Claus, Hackmann, John, Blohmer, Jens-Uwe, Rhiem, Kerstin, Schmitt, Wolfgang D., Furlanetto, Jenny, Gerber, Bernd, Huober, Jens, Nekljudova, Valentina, von Minckwitz, Gunter and Loibl, Sibylle (2019). NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto. J. Clin. Oncol., 37 (25). S. 2226 - 2244. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

von Waldenfels, Gabriel, Loibl, Sibylle, Furlanetto, Jenny, Anna, Machleidt, Lederer, Bianca, Denkert, Carsten, Hanusch, Claus, Huober, Jens, Jackisch, Christian, Kuemmel, Sherko, von Minckwitz, Gunter, Schneeweiss, Andreas, Untch, Michael, Rhiem, Kerstin, Fasching, Peter A. and Blohmer, Jens U. (2018). Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials. Cancer Res., 78 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445